The antimicrobial resistance profiles were provided by Phoenix BD automated system (Becton Dickinson Franklin Lakes, NJ, EUA); according to manufacturing protocols, each panel was standardized for Gram-positive and Gram-negative AST profiles comprehending the list below:
Aminoglycoside: Amikacin (AMK), Gentamicin (GEN), Synergism Gentamicin (SGEN), Synergism Streptomycin (SSTP), Tobramycin (TOB);
Cephalosporins: Cefepime (FEP), Cefoxitin (FOX), Ceftaroline (CPT), Ceftazidime (CAZ), Ceftazidime + Avibactam (CZA), Ceftriaxone (CRO), Cefuroxime (CXM), Cefazolin (CZ);
Quinolones: Ciprofloxacin (CIP), Norfloxacin (NX), Levofloxacin (LVX);
Penicillin: Amoxicillin/Clavulanic acid (AMC), Ampicillin (AMP), Ampicillin/Sulbactam (SAM), Oxacillin (OXA), Penicillin (PEN), Piperacillin/Tazobactam (TZP);
Carbapenems: Ertapenem (ETP), Imipenem (IPM), Meropenem (MEM);
Glycopeptides: Teicoplanin (TEC), Vancomycin (VAN):
Macrolide: Erythromycin (ERY), Rifampicin (RIP):
Lincosamides: Clindamycin (CLI);
Oxazolidinone: Linezolid (LZD);
Tetracycline: Tetracycline (TET), Minocycline (MIN);
Sulfonamides: Sulfamethoxazole/Trimethoprim (STX);
Nitroimidazoles: Nitrofurantoin (NIT);
Amphenicol: Chloramphenicol (C);
Phosphonate: Fosfomycin (FOS);
Glycylcyclines: Tigecycline (TGC);
Polypeptide: Colistin (CL);
Lipopeptides: Daptomycin (DAP).
The resistance profile was classified as resistant (R), and susceptible (S). Any isolate with resistance to three or more classes of antimicrobial agents was classified as multidrug-resistant (MDR) according to the definition proposed by Magiorakos et al. (2012) (
link). Some of the clinical isolates were retrieved at the moment of hospitalization for epidemiological active surveillance and infection control. A total of 256 isolates were included in the study and 196 had the antimicrobial susceptibility test performed (
Table 1).
Data for new COVID-19 cases for each month were obtained from the Brazilian Ministry of Health (MS) and the State Health Department of Rio de Janeiro, compiled by Cota (2020) .
The prevalence of bacteria species in pediatric, neonatal-ICU, and gynecology/obstetrics wards during the pandemic period was evaluated. In order to compare these three wards with other hospital wards, a total of 2,551 bacteria isolates were recovered from the HICC-HUAP.
Pinheiro F.R., Rozza-de-Menezes R.E., Blum M.C., Pereira R.F., Rocha J.A., Guedes Pinto M.C., Penna B.A., Riley L.W, & Aguiar-Alves F. (2023). Evaluation of changes in antimicrobial susceptibility in bacteria infecting children and their mothers in pediatric, neonatal-intensive care unit, and gynecology/obstetrics wards of a quaternary referral hospital during the COVID-19 pandemic. Frontiers in Microbiology, 14, 1096223.